Perspective from NHANES Data: Synergistic Effects of Visceral Adiposity Index and Lipid Accumulation Products on Diabetes Risk

Overview

Journal Sci Rep

Specialty Science

Date 2025 Jan 2

PMID 39747273

Authors

Jianhua He

Lei Chen

Affiliations

Soon will be listed here.

Abstract

This study aimed to explore the synergistic effect of lipid accumulation product (LAP) and visceral adiposity index (VAI) on diabetes risk, and to evaluate the potential associations of these novel metabolic markers with diabetes. The current cross-sectional survey utilised data from the 2015-2018 National Health and Nutrition Examination Survey (NHANES). The relationship between LAP and VAI levels and diabetes was examined using multiple logistic regression analysis. Moreover, threshold effects analysis and smoothed curve fitting were used as analytical techniques. The diabetes group exhibited significantly higher LAP (90.1 ± 84.1) and VAI (2.8 ± 2.8) levels compared to the non-diabetes group (p < 0.0001).After adjusting for confounding factors, LAP (OR = 1.01, 95% CI: 1.00-1.01, p < 0.0001) and VAI (OR = 1.22, 95% CI: 1.16-1.28, p < 0.0001) were independently associated with diabetes risk. The interaction term (LAP x VAI) showed a significant synergistic effect (OR = 1.01, 95% CI: 1.00-1.07, p = 0.0042).Diabetes risk significantly increased when LAP was below 97.70 (OR = 1.03, 95% CI: 1.02-1.03, p < 0.0001) and when VAI was below 3.76 (OR = 1.88, 95% CI: 1.69-2.08, p < 0.0001). According to this study, LAP and VAI are independent predictors of diabetes risk and exhibit a significant synergistic effect. Combining these indices may improve the accuracy of diabetes screening.

References

Al-Qudah S, Kasabri V, Saleh M, Suyagh M, AlAlawi S, Yasin N . Cross-sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes. Horm Mol Biol Clin Investig. 2018; 36(3). DOI: 10.1515/hmbci-2018-0035. View

Al-Batsh M, Albsoul-Younes A, Kasabri V, Suyagh M, AlAlawi S, Yasin N . Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes. Horm Mol Biol Clin Investig. 2018; 36(3). DOI: 10.1515/hmbci-2018-0058. View

Acheampong E, Adua E, Obirikorang C, Anto E, Peprah-Yamoah E, Obirikorang Y . Predictive modelling of metabolic syndrome in Ghanaian diabetic patients: an ensemble machine learning approach. J Diabetes Metab Disord. 2024; 23(2):2233-2249. PMC: 11599523. DOI: 10.1007/s40200-024-01491-7. View

Rattanatham R, Tangpong J, Chatatikun M, Sun D, Kawakami F, Imai M . Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers. PeerJ. 2023; 11:e15463. PMC: 10234272. DOI: 10.7717/peerj.15463. View

Deng H, Hu P, Li H, Zhou H, Wu X, Yuan M . Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study. Cardiovasc Diabetol. 2022; 21(1):212. PMC: 9571423. DOI: 10.1186/s12933-022-01660-z. View

Hamzeh B, Pasdar Y, Mirzaei N, Safari Faramani R, Najafi F, Shakiba E . Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis. 2021; 20(1):82. PMC: 8327427. DOI: 10.1186/s12944-021-01505-w. View

Shu L, Zhao Y, Shen Y, Jia L, Zhang J . Interaction analysis of lipid accumulation product and family history of diabetes on impaired fasting glucose and diabetes risk in population with normotension in Eastern China: a community-based cross-sectional survey. Arch Public Health. 2022; 80(1):217. PMC: 9526958. DOI: 10.1186/s13690-022-00972-6. View

Wei B, Zhou L, Shu B, Huang Q, Chai H, Yuan H . Association of diabetic retinopathy with plasma atherosclerotic index, visceral obesity index, and lipid accumulation products: NHANES 2005-2008. Lipids Health Dis. 2024; 23(1):331. PMC: 11465674. DOI: 10.1186/s12944-024-02325-4. View

Abildgaard J, Ploug T, Al-Saoudi E, Wagner T, Thomsen C, Ewertsen C . Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass. Sci Rep. 2021; 11(1):14750. PMC: 8292317. DOI: 10.1038/s41598-021-94189-2. View

10.

Jablonowska-Lietz B, Wrzosek M, Wlodarczyk M, Nowicka G . New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol. 2017; 75(11):1185-1191. DOI: 10.5603/KP.a2017.0149. View

11.

Huang X, Hu L, Tao S, Xue T, Hou C, Li J . Relationship between uric acid to high-density cholesterol ratio (UHR) and circulating α-klotho: evidence from NHANES 2007-2016. Lipids Health Dis. 2024; 23(1):244. PMC: 11312937. DOI: 10.1186/s12944-024-02234-6. View

12.

Lim S, Kim Y, Khang A, Eckel R . Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or type 2 diabetes. Clin Nutr. 2021; 40(11):5538-5546. DOI: 10.1016/j.clnu.2021.09.004. View

13.

Liu L, Peng J, Zang D, Zhang Y, Wu Z, Song C . The Chinese visceral adiposity index: a novel indicator more closely related to cardiovascular disease than other abdominal obesity indices among postmenopausal women. J Transl Med. 2024; 22(1):855. PMC: 11421114. DOI: 10.1186/s12967-024-05665-y. View

14.

Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C . Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020; 19(1):118. PMC: 7395356. DOI: 10.1186/s12933-020-01095-4. View

15.

Qiu J, Kuang M, Zou Y, Yang R, Shangguan Q, Liu D . The predictive significance of lipid accumulation products for future diabetes in a non-diabetic population from a gender perspective: an analysis using time-dependent receiver operating characteristics. Front Endocrinol (Lausanne). 2023; 14:1285637. PMC: 10682705. DOI: 10.3389/fendo.2023.1285637. View

16.

Rabiei N, Heshmat R, Gharibzadeh S, Ostovar A, Maleki V, Sadeghian M . Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord. 2021; 20(2):1439-1447. PMC: 8630247. DOI: 10.1007/s40200-021-00882-4. View

17.

Kittiskulnam P, Johansen K . The obesity paradox: A further consideration in dialysis patients. Semin Dial. 2019; 32(6):485-489. PMC: 6848753. DOI: 10.1111/sdi.12834. View

18.

Wang Y, Zhang X, Li Y, Gui J, Mei Y, Yang X . Obesity- and lipid-related indices as a predictor of type 2 diabetes in a national cohort study. Front Endocrinol (Lausanne). 2024; 14:1331739. PMC: 10864443. DOI: 10.3389/fendo.2023.1331739. View

19.

Lee H, Jo H, Kim Y, Kim S, Joo J, Lee K . Predictive Value of Lipid Accumulation Product, Fatty Liver Index, Visceral Adiposity Index for Metabolic Syndrome According to Menopausal Status. Metab Syndr Relat Disord. 2018; 16(9):477-482. DOI: 10.1089/met.2018.0019. View

20.

Deng C, Ke X, Lin L, Fan Y, Li C . Association between indicators of visceral lipid accumulation and infertility: a cross-sectional study based on U.S. women. Lipids Health Dis. 2024; 23(1):186. PMC: 11170861. DOI: 10.1186/s12944-024-02178-x. View